Elsevier

The Lancet

Volume 374, Issue 9698, 17–23 October 2009, Pages 1310-1312
The Lancet

Comment
StaR Child Health: an initiative for RCTs in children

https://doi.org/10.1016/S0140-6736(09)61803-1Get rights and content

First page preview

First page preview
Click to open first page preview

References (15)

There are more references available in the full text version of this article.

Cited by (53)

  • Consent and Assent in Pediatric Research

    2024, Pediatric Clinics of North America
  • Discontinuation and nonpublication of pediatric otolaryngology clinical trials

    2021, International Journal of Pediatric Otorhinolaryngology
    Citation Excerpt :

    Clinical trials are the foundation for advancing treatment modalities and determining methods to improve patient outcomes [1–3]. However, in the pediatric patient population, safety and efficacy outcomes for treatments are surprisingly scarce [4–7]. Consequently, children may be given ineffective treatments with potentially harmful side effects [8].

  • StaR Child Health: Improving global standards for child health research

    2013, Early Human Development
    Citation Excerpt :

    StaR Child Health was founded in 2009 to live up to the expectations of patients and parents. StaR addresses the paucity and shortcomings of pediatric clinical trials and develops solutions for the most pressing challenges [9]. This global initiative involves methodologists, clinicians, and policy makers dedicated to developing practical, evidence-based standards to enhance the reliability and relevance of pediatric clinical research.

View all citing articles on Scopus
View full text